🎉 M&A multiples are live!
Check it out!

BioLife Solutions Valuation Multiples

Discover revenue and EBITDA valuation multiples for BioLife Solutions and similar public comparables like Sopharma, Etropal, and Farmaceutica Remedia.

BioLife Solutions Overview

About BioLife Solutions

BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.


Founded

1987

HQ

United States of America
Employees

159

Financials

LTM Revenue $90.1M

LTM EBITDA $18.4M

EV

$1.0B

Valuation Multiples

Multiples.vc

Sign up to see

Valuation Multiples for 12K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

BioLife Solutions Financials

BioLife Solutions has a last 12-month revenue (LTM) of $90.1M and a last 12-month EBITDA of $18.4M.

In the most recent fiscal year, BioLife Solutions achieved revenue of $82.3M and an EBITDA of $1.5M.

BioLife Solutions expects next 12-month revenue of  XXX    and NTM EBITDA of  XXX

See BioLife Solutions valuation multiples based on analyst estimates

BioLife Solutions P&L

LTM NTM Last FY FY 2025 FY 2026 FY 2027
Revenue $90.1M XXX $82.3M XXX XXX XXX
Gross Profit $53.6M XXX $53.7M XXX XXX XXX
Gross Margin 60% XXX 65% XXX XXX XXX
EBITDA $18.4M XXX $1.5M XXX XXX XXX
EBITDA Margin 20% XXX 2% XXX XXX XXX
EBIT -$5.6M XXX -$7.1M XXX XXX XXX
EBIT Margin -6% XXX -9% XXX XXX XXX
Net Profit -$7.8M XXX -$20.2M XXX XXX XXX
Net Margin -9% XXX -25% XXX XXX XXX
Net Debt XXX XXX n/a XXX XXX XXX

Financial data powered by Morningstar, Inc.

BioLife Solutions Stock Performance

As of July 4, 2025, BioLife Solutions's stock price is $23.

BioLife Solutions has current market cap of $1.1B, and EV of $1.0B.

See BioLife Solutions trading valuation data

BioLife Solutions Stock Data

EV Market Cap Price 1D Price 1M Price 3M Price 12M EPS
$1.0B $1.1B XXX XXX XXX XXX $-0.16

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Start Free Trial

BioLife Solutions Valuation Multiples

As of July 4, 2025, BioLife Solutions has market cap of $1.1B and EV of $1.0B.

BioLife Solutions's trades at 12.5x EV/Revenue multiple, and 668.8x EV/EBITDA.

Equity research analysts estimate BioLife Solutions's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

BioLife Solutions has a P/E ratio of -139.8x.

See valuation multiples for BioLife Solutions and 12K+ public comps

BioLife Solutions Financial Valuation Multiples

LTM NTM Last FY FY 2025 FY 2026 FY 2027
Market cap (current) $1.1B XXX $1.1B XXX XXX XXX
EV (current) $1.0B XXX $1.0B XXX XXX XXX
EV/Revenue 11.4x XXX 12.5x XXX XXX XXX
EV/EBITDA 55.6x XXX 668.8x XXX XXX XXX
EV/EBIT -183.3x XXX -143.7x XXX XXX XXX
EV/Gross Profit 19.1x XXX n/a XXX XXX XXX
P/E -139.8x XXX -53.8x XXX XXX XXX
EV/FCF 138.0x XXX 208.9x XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get BioLife Solutions Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Start Free Trial

BioLife Solutions Margins & Growth Rates

BioLife Solutions's last 12 month revenue growth is 18%

BioLife Solutions's revenue per employee in the last FY averaged $0.5M, while opex per employee averaged $0.4M for the same period.

BioLife Solutions's rule of 40 is -13% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

BioLife Solutions's rule of X is 66% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for BioLife Solutions and other 12K+ public comps

BioLife Solutions Operational Valuation Multiples

LTM NTM Last FY FY 2025 FY 2026 FY 2027
Revenue Growth 18% XXX 18% XXX XXX XXX
EBITDA Margin 20% XXX 2% XXX XXX XXX
EBITDA Growth 38% XXX n/a XXX XXX XXX
Rule of 40 -13% XXX 20% XXX XXX XXX
Bessemer Rule of X XXX XXX 66% XXX XXX XXX
Revenue per Employee XXX XXX $0.5M XXX XXX XXX
Opex per Employee XXX XXX $0.4M XXX XXX XXX
S&M Expenses to Revenue XXX XXX 12% XXX XXX XXX
G&A Expenses to Revenue XXX XXX n/a XXX XXX XXX
R&D Expenses to Revenue XXX XXX 10% XXX XXX XXX
Opex to Revenue XXX XXX 74% XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics
Pharma Analytics
Private Equity
ERP Software
Developer Tools
Consumer SaaS
Streaming Platforms

BioLife Solutions Public Comps

See public comps and valuation multiples for Medical Supplies and Laboratory Services comps
EV/Revenue EV/EBITDA
2025E 2026E 2027E 2025E 2026E 2027E
Ansell XXX XXX XXX XXX XXX XXX
Polymed XXX XXX XXX XXX XXX XXX
Farmaceutica Remedia XXX XXX XXX XXX XXX XXX
Etropal XXX XXX XXX XXX XXX XXX
Sopharma XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX

Valuation data powered by FactSet, Inc.

BioLife Solutions M&A and Investment Activity

BioLife Solutions acquired  XXX companies to date.

Last acquisition by BioLife Solutions was  XXXXXXXX, XXXXX XXXXX XXXXXX . BioLife Solutions acquired  XXXXXXXX for  XXX (EV/Revenue multiple of  XXX ).

See M&A valuation multiples

Latest Acquisitions by BioLife Solutions

Acquired Company EV EV/Revenue EV/EBITDA
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.

Start Free Trial

About BioLife Solutions

When was BioLife Solutions founded? BioLife Solutions was founded in 1987.
Where is BioLife Solutions headquartered? BioLife Solutions is headquartered in United States of America.
How many employees does BioLife Solutions have? As of today, BioLife Solutions has 159 employees.
Who is the CEO of BioLife Solutions? BioLife Solutions's CEO is Mr. Roderick De Greef.
Is BioLife Solutions publicy listed? Yes, BioLife Solutions is a public company listed on NAS.
What is the stock symbol of BioLife Solutions? BioLife Solutions trades under BLFS ticker.
When did BioLife Solutions go public? BioLife Solutions went public in 1989.
Who are competitors of BioLife Solutions? Similar companies to BioLife Solutions include e.g. Ansell, Polymed, Farmaceutica Remedia, Etropal.
What is the current market cap of BioLife Solutions? BioLife Solutions's current market cap is $1.1B
What is the current revenue of BioLife Solutions? BioLife Solutions's last 12 months revenue is $90.1M.
What is the current revenue growth of BioLife Solutions? BioLife Solutions revenue growth (NTM/LTM) is 18%.
What is the current EV/Revenue multiple of BioLife Solutions? Current revenue multiple of BioLife Solutions is 11.4x.
Is BioLife Solutions profitable? Yes, BioLife Solutions is EBITDA-positive (as of the last 12 months).
What is the current EBITDA of BioLife Solutions? BioLife Solutions's last 12 months EBITDA is $18.4M.
What is BioLife Solutions's EBITDA margin? BioLife Solutions's last 12 months EBITDA margin is 20%.
What is the current EV/EBITDA multiple of BioLife Solutions? Current EBITDA multiple of BioLife Solutions is 55.6x.
What is the current FCF of BioLife Solutions? BioLife Solutions's last 12 months FCF is $7.4M.
What is BioLife Solutions's FCF margin? BioLife Solutions's last 12 months FCF margin is 8%.
What is the current EV/FCF multiple of BioLife Solutions? Current FCF multiple of BioLife Solutions is 138.0x.

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.